bezalip ( bezafibrate ) , at an oral dosage of 200 mg three times a day , has been used on 12 patients with idiopathic hyperlipidemia , and on 12 patients with hyperlipidemia superimposed with diabetes mellitus .
C0591179
bezalip
C0005330
bezafibrate